Attitudes, management and consequences of nausea and vomiting of pregnancy in the United States and Canada

International Journal of Gynecology and Obstetrics

Volumn 70, Issue 3, 2000, Pages 359-365

  Mazzotta, P ^a   Maltepe, C ^a   Navioz, Y ^a   Magee, L A ^b   Koren, G ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Bendectin Diclectin ; Canada; Nausea and vomiting of pregnancy; United States

Indexed keywords

ANTIEMETIC AGENT; BENDECTIN; DIMENHYDRINATE; DOXYLAMINE; MULTIVITAMIN; PHENOTHIAZINE; PROCHLORPERAZINE; PROMETHAZINE; PYRIDOXINE;

ADULT; ARTICLE; CANADA; DRUG APPROVAL; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MAJOR CLINICAL STUDY; NAUSEA; PATIENT ATTITUDE; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; UNITED STATES; VOMITING;

EID: 0034283916     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(00)00255-1     Document Type: Article

References (10)

1. O'Brien B., Zhou Q. Variables related to nausea and vomiting during pregnancy. Birth. 22:1995;93-100.
2. Emelianova S., Mazzotta P., Einarson A., Koren G. Prevalence and severity of nausea and vomiting of pregnancy and effect of vitamin supplementation. Clin Invest Med. 22:1999;106-110.
3. Gadsby R., Barnie-Adshead A.M., Jagger C. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract. 43:1993;245-248.
4. Einarson T., Leeder S., Koren G. A method for meta-analysis of epidemiological studies. Drug Intell Clin Pharm. 22:1988;813-824.
5. Ornstein M., Einarson A., Koren G. Bendectin/Diclectin for morning sickness; a Canadian follow-up of an American tragedy. Reprod Toxicol. 9:1995;1-6.
6. Mazzotta P., Magee L.A., Maltepe C., Lifshitz A., Navioz I., Koren G. The perception of teratogenic risk by women with nausea and vomiting of pregnancy. Reprod Toxicol. 13:1999;313-319.
7. Mazzotta P., Magee L. A risk-benefit assessment of pharmacological and non-pharmacological treatments for nausea and vomiting of pregnancy. Drugs. 59(4):2000;781-800.
8. Neutel C.I., Johansen H.L. Measuring drug effectiveness by default: the case of bendectin. Can J Publ Health. 86:1995;66-70.
9. ® use in Canada. Koren G., Bishai R. NVP-State of the Art 2000. The Motherisk Program, Toronto. (in press).
10. Koren G., Pastuszak A.L. Prevention of unnecessary pregnancy terminations by counseling women on drug, chemical, and radiation exposure during the first trimester. Teratology. 41:1990;657-661.